Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

International Flavors & Fragrances Inc ha un obiettivo di prezzo di consenso pari a $86.9, stabilito in base alle ultime valutazioni degli analisti di 23. Le ultime 3 valutazioni degli analisti sono state rilasciate da B of A Securities, Argus Research y UBS il octubre 14, 2025, octubre 7, 2025 y octubre 6, 2025. Con un obiettivo di prezzo medio di $72 tra le B of A Securities, Argus Research y UBS, c'è un implicito 14.34% upside per International Flavors & Fragrances Inc da queste valutazioni degli analisti.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/14/2025 | 27.04% | B of A Securities | $84 → $80 | Maintains | Buy | |||
10/07/2025 | 11.16% | Argus Research | $85 → $70 | Maintains | Buy | |||
10/06/2025 | 4.81% | UBS | $71 → $66 | Maintains | Neutral | |||
10/06/2025 | 19.1% | Citigroup | $82 → $75 | Maintains | Buy | |||
10/03/2025 | 19.1% | Mizuho | $85 → $75 | Maintains | Outperform | |||
09/22/2025 | 42.93% | Morgan Stanley | $92 → $90 | Maintains | Overweight | |||
09/08/2025 | — | Wolfe Research | — | Upgrade | Underperform → Peer Perform | |||
08/26/2025 | 66.75% | Tigress Financial | $105 → $105 | Maintains | Buy | |||
08/08/2025 | 23.87% | Barclays | $84 → $78 | Maintains | Overweight | |||
08/07/2025 | 34.98% | Wells Fargo | $90 → $85 | Maintains | Overweight | |||
08/06/2025 | 25.46% | UBS | $83 → $79 | Maintains | Neutral | |||
06/04/2025 | 66.75% | Tigress Financial | → $105 | Initiates | → Buy | |||
05/13/2025 | 55.63% | Morgan Stanley | $100 → $98 | Maintains | Overweight | |||
05/08/2025 | 42.93% | Citigroup | $84 → $90 | Maintains | Buy | |||
05/08/2025 | 58.81% | Baird | $110 → $100 | Maintains | Outperform | |||
05/08/2025 | 33.4% | Barclays | $76 → $84 | Upgrade | Equal-Weight → Overweight | |||
05/07/2025 | 31.81% | UBS | $82 → $83 | Maintains | Neutral | |||
04/22/2025 | 41.34% | Oppenheimer | $104 → $89 | Maintains | Outperform | |||
04/15/2025 | 38.16% | Mizuho | $95 → $87 | Maintains | Outperform | |||
04/14/2025 | 20.69% | Barclays | $82 → $76 | Maintains | Equal-Weight | |||
04/10/2025 | 58.81% | Morgan Stanley | $106 → $100 | Maintains | Overweight | |||
04/10/2025 | 44.51% | Stifel | $105 → $91 | Maintains | Buy | |||
04/09/2025 | 42.93% | Wells Fargo | $105 → $90 | Maintains | Overweight | |||
04/08/2025 | 33.4% | Citigroup | $99 → $84 | Maintains | Buy | |||
03/27/2025 | 30.22% | Barclays | $83 → $82 | Maintains | Equal-Weight | |||
02/20/2025 | 65.16% | Oppenheimer | $114 → $104 | Maintains | Outperform | |||
02/20/2025 | 65.16% | JP Morgan | $107 → $104 | Maintains | Overweight | |||
02/20/2025 | 60.39% | B of A Securities | $105 → $101 | Maintains | Buy | |||
02/20/2025 | 66.75% | Wells Fargo | $115 → $105 | Maintains | Overweight | |||
02/03/2025 | 66.75% | Stifel | $113 → $105 | Maintains | Buy | |||
01/28/2025 | 81.04% | Oppenheimer | $117 → $114 | Maintains | Outperform | |||
01/17/2025 | 39.75% | Barclays | $90 → $88 | Maintains | Equal-Weight | |||
01/07/2025 | — | Argus Research | — | Upgrade | Hold → Buy | |||
12/18/2024 | 66.75% | Citigroup | $110 → $105 | Maintains | Buy | |||
11/12/2024 | 74.69% | Morgan Stanley | $111 → $110 | Upgrade | Equal-Weight → Overweight | |||
11/08/2024 | 69.92% | B of A Securities | $109 → $107 | Upgrade | Neutral → Buy | |||
11/07/2024 | 69.92% | JP Morgan | $110 → $107 | Maintains | Overweight | |||
11/07/2024 | 73.1% | Vertical Research | — | → $109 | Upgrade | Hold → Buy | ||
11/06/2024 | 76.27% | UBS | $108 → $111 | Maintains | Neutral | |||
10/24/2024 | 92.15% | Stifel | $115 → $121 | Maintains | Buy | |||
10/11/2024 | 57.22% | Barclays | $93 → $99 | Maintains | Equal-Weight | |||
09/11/2024 | 85.8% | Oppenheimer | $116 → $117 | Maintains | Outperform | |||
09/06/2024 | 74.69% | JP Morgan | $102 → $110 | Maintains | Overweight | |||
09/03/2024 | 90.57% | Mizuho | $109 → $120 | Upgrade | Neutral → Outperform | |||
08/15/2024 | 63.57% | UBS | $107 → $103 | Maintains | Neutral | |||
08/08/2024 | 61.98% | JP Morgan | $100 → $102 | Maintains | Overweight | |||
08/08/2024 | 82.63% | Wells Fargo | $110 → $115 | Maintains | Overweight | |||
08/07/2024 | 69.92% | UBS | $100 → $107 | Maintains | Neutral | |||
07/22/2024 | 82.63% | Stifel | $95 → $115 | Upgrade | Hold → Buy | |||
07/12/2024 | 84.21% | Citigroup | $108 → $116 | Maintains | Buy | |||
07/09/2024 | 58.81% | UBS | $95 → $100 | Maintains | Neutral | |||
07/03/2024 | 63.57% | Morgan Stanley | $100 → $103 | Maintains | Equal-Weight | |||
06/07/2024 | 84.21% | Oppenheimer | → $116 | Initiates | → Outperform | |||
05/21/2024 | 58.81% | Morgan Stanley | $100 → $100 | Downgrade | Overweight → Equal-Weight | |||
05/10/2024 | 57.22% | B of A Securities | $87 → $99 | Maintains | Neutral | |||
05/08/2024 | 71.51% | Citigroup | $100 → $108 | Maintains | Buy | |||
05/08/2024 | 47.69% | Barclays | $82 → $93 | Maintains | Equal-Weight | |||
05/08/2024 | 74.69% | Wells Fargo | $100 → $110 | Maintains | Overweight | |||
05/08/2024 | 58.81% | JP Morgan | $75 → $100 | Upgrade | Neutral → Overweight | |||
05/08/2024 | 74.69% | Baird | $100 → $110 | Maintains | Outperform | |||
05/07/2024 | 50.87% | Stifel | $87 → $95 | Maintains | Hold | |||
05/07/2024 | 55.63% | Mizuho | $91 → $98 | Maintains | Neutral | |||
04/12/2024 | 19.1% | Barclays | $69 → $75 | Maintains | Underweight | |||
04/10/2024 | 58.81% | Citigroup | $81 → $100 | Upgrade | Neutral → Buy | |||
04/04/2024 | 58.81% | Wells Fargo | $90 → $100 | Maintains | Overweight | |||
03/27/2024 | 52.45% | Morgan Stanley | $89 → $96 | Maintains | Overweight | |||
03/20/2024 | 58.81% | Deutsche Bank | $90 → $100 | Maintains | Buy | |||
03/20/2024 | 44.51% | Mizuho | $83 → $91 | Maintains | Neutral | |||
03/08/2024 | — | Argus Research | — | Downgrade | Buy → Hold | |||
03/01/2024 | — | Wolfe Research | — | Initiates | → Underperform | |||
02/26/2024 | 31.81% | Mizuho | $82 → $83 | Maintains | Neutral | |||
02/23/2024 | 28.63% | Citigroup | $85 → $81 | Maintains | Neutral | |||
02/22/2024 | 42.93% | Wells Fargo | $85 → $90 | Maintains | Overweight | |||
02/22/2024 | 34.98% | Baird | $80 → $85 | Maintains | Outperform | |||
02/21/2024 | 30.22% | Mizuho | $86 → $82 | Maintains | Neutral | |||
02/21/2024 | 27.04% | Stifel | $87 → $80 | Maintains | Hold | |||
01/22/2024 | 42.93% | Morgan Stanley | $81 → $90 | Upgrade | Equal-Weight → Overweight | |||
01/12/2024 | 9.58% | Barclays | $64 → $69 | Maintains | Underweight | |||
01/12/2024 | 77.86% | Jefferies | $73 → $112 | Upgrade | Hold → Buy | |||
01/11/2024 | 30.22% | UBS | $78 → $82 | Maintains | Neutral | |||
12/20/2023 | 38.16% | Stifel | $81 → $87 | Maintains | Hold | |||
12/06/2023 | 28.63% | Morgan Stanley | $75 → $81 | Maintains | Equal-Weight | |||
11/28/2023 | 34.98% | Argus Research | → $85 | Upgrade | Hold → Buy | |||
11/13/2023 | 23.87% | UBS | $88 → $78 | Downgrade | Buy → Neutral | |||
11/08/2023 | 34.98% | Wells Fargo | $80 → $85 | Maintains | Overweight | |||
11/07/2023 | 38.16% | Stifel | $77 → $87 | Maintains | Hold | |||
10/12/2023 | -9.48% | Barclays | $60 → $57 | Maintains | Underweight | |||
10/12/2023 | -4.72% | Redburn Atlantic | → $60 | Initiates | → Neutral | |||
09/14/2023 | 28.63% | Stifel | $81 → $81 | Reiterates | Hold → Hold | |||
08/24/2023 | 19.1% | Morgan Stanley | $112 → $75 | Downgrade | Overweight → Equal-Weight | |||
08/10/2023 | 23.87% | Goldman Sachs | $120 → $78 | Maintains | Neutral | |||
08/10/2023 | -4.72% | Barclays | $75 → $60 | Maintains | Underweight | |||
08/09/2023 | 6.4% | JP Morgan | $83 → $67 | Maintains | Neutral | |||
08/09/2023 | 34.98% | Deutsche Bank | $110 → $85 | Maintains | Buy | |||
08/09/2023 | 27.04% | Wells Fargo | $93 → $80 | Maintains | Overweight | |||
08/09/2023 | 23.87% | Goldman Sachs | $120 → $78 | Downgrade | Buy → Neutral | |||
08/09/2023 | 11.16% | Citigroup | $84 → $70 | Maintains | Neutral | |||
08/08/2023 | 50.87% | Credit Suisse | $110 → $95 | Maintains | Outperform | |||
08/08/2023 | 34.98% | Stifel | $123 → $85 | Downgrade | Buy → Hold | |||
07/18/2023 | 90.57% | Goldman Sachs | $134 → $120 | Maintains | Buy |
El último precio objetivo de Intl Flavors & Fragrances (NYSE:IFF) fue comunicado por B of A Securities el octubre 14, 2025. La firma de analistas fijó un precio objetivo para $80.00 que espera IFF a rise dentro de 12 meses (un posible 27.04% upside). 39 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para Intl Flavors & Fragrances (NYSE:IFF) fue proporcionada por B of A Securities, y Intl Flavors & Fragrances mantuvo su buy calificación.
La última revisión al alza de International Flavors & Fragrances Inc se produjo en septiembre 8, 2025, cuando Wolfe Research elevó su precio objetivo a N/A. Wolfe Research anteriormente tenía an underperform para International Flavors & Fragrances Inc.
La última revisión a la baja de International Flavors & Fragrances Inc se produjo en mayo 21, 2024, cuando Morgan Stanley cambió su precio objetivo de $100 a $100 para International Flavors & Fragrances Inc.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Intl Flavors & Fragrances, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Intl Flavors & Fragrances se registró el octubre 14, 2025, por lo que la próxima calificación estará disponible en torno al octubre 14, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Intl Flavors & Fragrances (IFF) fue un mantuvo con un precio objetivo de $84.00 a $80.00. El precio actual al que cotiza Intl Flavors & Fragrances (IFF) es de $62.97, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.